Description
AOD-9604 is a synthetic peptide fragment of human growth hormone (HGH), composed of amino acids 176–191 at the C-terminal end of the HGH molecule. Researchers discovered that this specific sequence is responsible for much of HGH’s fat-burning activity without its growth-promoting effects.
Benefits of AOD-9604 :
When dosed consistently, AOD-9604 provides targeted fat-burning and metabolic support without the systemic hormonal risks seen with full-length HGH.
- Fat Loss and Body Composition : Accelerates fat breakdown, Prevents fat storage, Targets abdominal/visceral fat
- Metabolic Health
- Joint and Recovery Benefits
- Advantages Over Other Fat-Loss Therapies : No IGF-1 elevation, Non-stimulant (Suitable for individuals sensitive to caffeine or thermogenics)
AOD-9604 Dosage Protocols
AOD-9604 is typically administered via subcutaneous injection, In both clinical research and wellness settings, dosing is relatively consistent — low microgram amounts designed for daily use.
Standard Clinical Dosage :
- 200–500 mcg daily, delivered as a subcutaneous injection in the abdominal region.
- Best administered in the morning, when fat mobilization is naturally higher.
- Clinical trials investigating obesity used these dosing ranges with favorable safety outcomes
Wellness Protocols :
- 250–500 mcg daily, injected once per day, is the most common practice in weight loss clinics and peptide protocols.
- Some practitioners recommend splitting the dose into two daily injections (AM + PM) to maintain steady exposure.
- Often paired with diet and exercise regimens for enhanced fat-loss results.
Cycle Length and Best Practices
Typical Cycle Lengths :
- Weight loss protocols: 4–12 weeks, depending on goals and response.
- Clinical trial durations: Most obesity studies used daily dosing for 12 weeks
- Wellness clinic use: Often structured in 8-week cycles, followed by reassessment before continuing.
Best Practices :
- Consistency matters: AOD-9604 is most effective when dosed daily without skipping, as its effects are gradual.
- Stacking considerations: Can be combined with lifestyle interventions (calorie deficit, exercise) and, in some protocols, with other peptides such as CJC-1295/Ipamorelin for enhanced metabolic impact.
- Injection site rotation: Rotate subcutaneous injection sites to reduce irritation.
- Timing: Morning injections are preferred, aligning with natural circadian fat metabolism.
Common Peptide Stacks :
→ AOD-9604 + CJC-1295/Ipamorelin:
Combining AOD-9604 with growth hormone secretagogues enhances overall fat metabolism. CJC-1295 and Ipamorelin stimulate endogenous HGH release, while AOD-9604 targets fat directly without affecting IGF-1. This dual action can accelerate fat loss and body recomposition.
→ AOD-9604 + BPC-157 or TB-500:
For individuals prioritizing recovery and joint health alongside fat loss, AOD-9604 may be paired with healing peptides. This is particularly useful for athletes cutting weight while managing training injuries.
With Anabolic Steroids or SARMs :
→ Cutting cycles: AOD-9604 is sometimes added to anabolic or SARM-based cutting protocols (e.g., Anavar, Winstrol, or Cardarine). It provides additional fat metabolism support without adding hormonal burden.
With Lifestyle and Supplements
→ Works best alongside a calorie-controlled diet, resistance training, and cardiovascular exercise.
→ Can be combined with non-stimulant fat burners (like L-carnitine) or mild thermogenics to enhance metabolic effects.
Side Effects of AOD-9604 :
- Injection site irritation: Redness, swelling, or itching at the subcutaneous injection site is the most frequent issue.
- Headache or fatigue: Occasionally reported, usually resolving without intervention.
